key: cord-0854238-5a654atz
authors: Mahalapbutr, Panupong; Kongtaworn, Napat; Rungrotmongkol, Thanyada
title: Structural Insight into the Recognition of S-Adenosyl-L-Homocysteine and Sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA Cap 2’-O-Methyltransferase
date: 2020-10-01
journal: Comput Struct Biotechnol J
DOI: 10.1016/j.csbj.2020.09.032
sha: 9b70ffa01726f690661361a4ec5790fb9e0efccc
doc_id: 854238
cord_uid: 5a654atz

The recent ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to rapidly spread across the world. To date, neither a specific antiviral drug nor a clinically effective vaccine is available. Among the 15 viral non-structural proteins (nsps), nsp16 methyltransferase has been considered as a potential target due to its crucial role in RNA cap 2’-O-methylation process, preventing the virus detection by cell innate immunity mechanisms. In the present study, molecular recognition between the two natural nucleoside analogs (S-adenosyl-L-homocysteine (SAH) and sinefungin (SFG)) and the SARS-CoV-2 nsp16/nsp10/(m7)G(ppp)AC(5) was studied using all-atom molecular dynamics simulations and free energy calculations based on MM/GBSA and WaterSwap approaches. The binding affinity and the number of hot-spot residues, atomic contacts, and H-bond formations of the SFG/nsp16 complex were distinctly higher than those of the SAH/nsp16 system, consistent with the lower water accessibility at the enzyme active site. Notably, only SFG could electrostatically interact with the 2’-OH and N3 groups of RNA’s adenosine moiety, mimicking the methyl transfer reaction of S-adenosyl-L-methionine substrate. The atomistic binding mechanism obtained from this work paves the way for further optimizations and designs of more specific SARS-CoV-2 nsp16 inhibitors in the fight against COVID-19.

The newly emerged coronavirus disease 2019 (COVID-19, designated by the World 45 Health Organization (WHO) on February 11, 2020 [1] ) caused by severe acute respiratory 46 syndrome coronavirus 2 (SARS-CoV-2) was firstly reported in Wuhan city, Hubei province, receptor, namely angiotensin-converting enzyme 2 (ACE2) [8] . After viral entry through the 59 endo-lysosomal pathway [9], the 5'-proximal two-thirds of the genome (open reading frames 60 1a and 1b) encodes two large overlapping replicase polyproteins (pp1a and pp1ab), which are 61 further processed by viral proteases (i.e., 3-chymotrypsin-like protease (3CL pro ) and papain-62 like protease (PL pro ) [10] ) to generate 15 non-structural proteins (nsps), termed nsp1 to nsp10 63 and nsp12 to nsp16 [4] . These cleavage products assemble into replicase-transcriptase 64 complex (RTC) or function as accessory proteins in the viral replication process [11, 12] . 65 The RTC possesses catalytic activities required for viral genome synthesis and 66 comprises most of the enzymes involved in 5'-guanosine cap formation [13] , enhancing the 67 mRNA stability and protecting mRNA from degradation by cellular 5'-3' exoribonucleases 68 [14] . According to CoV capping pathway [14, 15] , the 5'-methylated-blocked cap structure is 69 cotranscriptionally formed by four sequential enzymes: (i) an RNA triphosphatase (RTPase, Previous studies revealed that S-adenosyl-L-homocysteine (SAH, Fig. 1B) [25]). Then, the m7 G ppp A of SARS-CoV-2 nsp16 was linked to the A 5 pentamer from the VV 111 MTase at the position 3'-OH of A 1 moiety using the Accelrys Discovery Studio 2.5 Accelrys Inc 112 (DS2.5). After that, the generated model of m7 G ppp A 6 in SARS-CoV-2 nsp16 was modified to antechamber package was used to convert ESP charges to restrained ESP (RESP) charges. 127 The AMBER OL3 force field [34] and general AMBER force field version 2 (GAFF2) [35] 128 were adopted for m7 G ppp AC 5 parameters. Missing hydrogen atoms were added using the LEaP 129 module implemented in AMBER16. The AMBER ff14SB force field was applied for the 130 protein [36]. Subsequently, each system was solvated using the TIP3P water model [37] with 131 a spacing distance of 10 Å between the solvation box edge and the protein surface, and the 132 total charge of system was neutralized by incorporating sodium ions. The added hydrogen atoms and water molecules were then minimized using 1,000 steps of steepest descent 134 followed by 2,500 steps of conjugated gradient methods. Finally, the whole system was 135 minimized using the same minimization procedure. to the protein-ligand complex. In the next equilibrium phase, each complex was subjected to 144 restrained MD simulations at 310 K with the harmonic restraint of 30, 20, 10, 5, and 2.5 145 kcal/mol·Å 2 for 500 ps in total followed by unrestrained MD at 310 K for 500 ps. Free energy calculations 153 The binding free energy (ΔG bind ) and per-residue decomposition free energy (Δ residue bind 154 ) were calculated using the molecular mechanics/generalized Born surface area (MM/GBSA) 155 method [41, 42] on 100 MD snapshots extracted from the last 20 ns of the MD production phase. Note that only nsp16/ligand/RNA ternary complex in chain A was considered for free 157 energy calculations. 158 The ΔG bind consists of the molecular mechanics energy (ΔE MM ) in gas phase, 159 solvation free energy (ΔG solv ), and entropy term (S) as given in eq. 1.

(1)

The ΔE MM was obtained by combining electrostatic (ΔE ele ) and van der Waal (ΔE vdW ) 162 energies between ligand and its receptor, whereas the ΔG solv was calculated according to eq. 163 2. 164 ( Bennett's acceptance ratio, free energy perturbation, and quadrature-based integration of TI. Hot-spot residues 230 To investigate crucial amino acid residues associated with the binding of the two The obtained results demonstrated that there were 10 (N43, G71, G73, D99, L100, 240 C115, D130, M131, Y132, and F149) and 12 residues (N43, G71, A72, G73, D99, L100, 241 D114, C115, D130, M131, Y132, and F149) associated with the binding of SAH and SFG, 242 respectively. The higher contributing residues found in the SFG/SARS-CoV-2 nsp16 243 complex was in good agreement with the time evolution of #H-bonds (Fig. 2) electrostatic attraction and H-bond formation (Fig. 6, discussed later) , suggesting the most dramatically decreased not only the susceptibility (by ∼2 to 6 kcal/mol) but also the energy 251 contributions from several hot-spot residues, including N43, D99A, Y132, and F149 to the 252 binding of both nucleosides compared to the wild-type SARS-CoV-2 nsp16 (Fig. S1) . 253 However, further experimental validation (e.g., site-directed mutagenesis) should be 254 conducted. In addition to D99, residues L100, C115, M131, and F149 were found to stabilize 255 the adenine ring of SAH and SFG through vdW forces (up to ~ −3.0 kcal/mol, Fig. 4) . These (Fig. 3 and Fig. 4) . Therefore, we suggest to change this positively charged amino 265 group of SFG to other polar moieties (e.g., halogen atoms, carboxylate, etc.) in order to 266 impair charge-charge repulsion. However, it is worth noting that the amino group at 6' 267 position of SFG strongly interacted with the 2'-O and N3 atoms of adenosine moiety of RNA 268 substrate via electrostatic contributions and H-bond formations (Fig. 5 and Fig. 6) ; thus, to the ΔE MM results ( Table 1) . 280 From the calculation between m7 G ppp AC 5 RNA substrate and nucleoside Δ residue bind 281 analog(s) (Fig. 5A) , we found that only adenosine moiety of RNA plays a major role in the 282 recognition of both inhibitors. Notably, the of adenosine group in SFG system Δ residue bind 283 (−6.66 ± 1.23 kcal/mol) was ~10-fold lower than that in SAH model (−0.65 ± 0.03 kcal/mol). To characterize the effect of water accessibility on the SARS-CoV-2 nsp16 active 349 site, the solvent-accessible surface area (SASA) calculations were performed on the residues 350 within 5 Å of each nucleoside inhibitor (Fig. 7A) . Note that our complex model contained the 351 ligand binding only to chain A. As shown in Fig. 7B of SAH, as evidenced by the ΔG bind calculations ( Table 1) . 359 We further characterized the number of atomic contacts (#atom contacts) within 5 Å In this work, the binding pattern and susceptibility of the two nucleoside analogs SAH 376 and SFG in complex with SARS-CoV-2 nsp16/nsp10/ m7 G ppp AC 5 were fully revealed by all- 

COVID-19: fighting panic with information

The continuing 2019-nCoV epidemic threat of novel 399 coronaviruses to global health -The latest 2019 novel coronavirus outbreak in Wuhan, China, 400

Outbreak of pneumonia of unknown etiology in Wuhan, China: 402 The mystery and the miracle

Genome Composition and Divergence of the 405

Novel Coronavirus (2019-nCoV) Originating in China

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main 409 protease

Severe acute respiratory syndrome coronavirus-2 411 (SARS-CoV-2): a global pandemic and treatment strategies

The Architecture of SARS-CoV

Inhibition of SARS-CoV-2 Infections in Engineered Human 418 Tissues Using Clinical-Grade Soluble Human

COVID-19 infection: Origin, 420 transmission, and characteristics of human coronaviruses

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential 424 drugs by computational methods

Continuous and Discontinuous RNA Synthesis in 426 Coronaviruses

The crystal 429 structure of nsp10-nsp16 heterodimer from SARS-CoV-2 in complex with S-adenosylmethionine

Adenosyl-l-Methionine to Middle East Respiratory Syndrome Coronavirus 2'-O-433

Methyltransferase nsp16 Promotes Recruitment of the Allosteric Activator nsp10

Yeast-436 based assays for the high-throughput screening of inhibitors of coronavirus RNA cap guanine-N7-437 methyltransferase

Crystal structure 440 and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 441 complex

In vitro 443 reconstitution of SARS-coronavirus mRNA cap methylation

IFIT1: A dual sensor and effector molecule that detects non-2'-O methylated 446 viral RNA and inhibits its translation

Ribose 2′-O-methylation 449 provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA 450 sensor Mda5

Unique and conserved features of genome and proteome of SARS-453 coronavirus, an early split-off from the coronavirus group 2 lineage

The viral RNA capping machinery as a target for 456 antiviral drugs

Effects of S-adenosylhomocysteine analogues on vaccinia viral 458 messenger ribonucleic acid synthesis and methylation

Sinefungin, a potent inhibitor of virion mRNA(guanine-460 7-)-methyltransferase, mRNA(nucleoside-2'-)-methyltransferase, and viral multiplication

Crystal Structure of Nsp16-Nsp10 Heterodimer from SARS-CoV-2 in Complex with 7-methyl-463 GpppA and S-adenosyl-L-homocysteine

Structural basis for sequence-nonspecific recognition 467 of 5'-capped mRNA by a cap-modifying enzyme

Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing 470 (nucleoside-2'O)-methyltransferase activity

MarvinSketch and MarvinView: molecule applets for the World Wide Web, 472 Proceedings of ECSOC-3, the third international electronic conference on synthetic organic 473 chemistry

pKa based protonation states and microspecies for protein-ligand 475 docking

PROPKA3: Consistent 477 Treatment of Internal and Surface Residues in Empirical pKa Predictions

Gaussian 09

Butoxy Mansonone G Inhibits 491 STAT3 and Akt Signaling Pathways in Non-Small Cell Lung Cancers: Combined Experimental and 492 Theoretical Investigations

Enhanced Solubility and Anticancer Potential of Mansonone G By beta-495

Cyclodextrin-Based Host-Guest Complexation: A Computational and Experimental Study

Binding Hotspot and Activation Mechanism of 498

Maltitol and Lactitol toward the Human Sweet Taste Receptor

Revised RNA Dihedral 501 Parameters for the Amber Force Field Improve RNA Molecular Dynamics

Development and testing of a 504 general Amber force field

Simmerling, ff14SB: 506 Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB

Comparison of simple 509 potential functions for simulating liquid water

Particle mesh Ewald: An N·log(N) method for Ewald sums in 512 large systems

Numerical integration of the cartesian equations of 514 motion of a system with constraints: molecular dynamics of n-alkanes

PTRAJ and CPPTRAJ: Software for processing and analysis of 517 molecular dynamics trajectory data

The MM/PBSA and MM/GBSA methods to estimate ligand-binding 520 affinities

UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations

Calculating structures 527 and free energies of complex molecules: combining molecular mechanics and continuum models

Accurate Calculation of Hydration Free Energies Using 530

Macroscopic Solvent Models

A water-swap reaction coordinate 532 for the calculation of absolute protein-ligand binding free energies

Rapid 535 decomposition and visualisation of protein-ligand binding free energies by residue and by water

S-Adenosyl-Homocysteine Is a Weakly Bound Inhibitor for a Flaviviral 539

Biochemical and Structural Insights into the Mechanisms of SARS 542

Coronavirus RNA Ribose 2′-O-Methylation by nsp16/nsp10 Protein Complex

Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT)

Sinefungin 550 Derivatives as Inhibitors and Structure Probes of Protein Lysine Methyltransferase SETD2

Atomistic mechanisms underlying the activation of the G protein-coupled sweet 554 receptor heterodimer by sugar alcohol recognition

Two zinc-binding 556 domains in the transporter AdcA from Streptococcus pyogenes facilitate high-affinity binding and fast 557 transport of zinc

Rosmarinic 559 Acid as a Potent Influenza Neuraminidase Inhibitor: In Vitro and In Silico Study, Current Topics in 560